{"transactions":[{"id":3136536,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2020-05-22T21:13:33.000Z","date":"2020-05-21","kind":"grant","acquired":true,"shares":24000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":24000,"derivative":{"exercise_price":0.6261,"expiration_date":"2030-05-20","underlying":"Common Stock","underlying_shares":24000},"source":{"system":"sec-edgar","filing":"0001209191-20-031825","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000120919120031825/doc4.xml","form_type":"4"}},{"id":3480930,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-06-21T21:15:00.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":2.36,"expiration_date":"2029-06-18","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-19-038565","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000120919119038565/doc4.xml","form_type":"4"}},{"id":3561052,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2019-04-05T21:24:53.000Z","date":"2019-04-03","kind":"grant","acquired":true,"shares":10106,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). The shares vest in four equal\nquarterly installments beginning on January 1, 2019 through December 31, 2019, provided that at the relevant vesting dates the Reporting\nPerson's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The option expires 10 years\nafter the date of grant."}],"balance_after":10106,"derivative":{"exercise_price":2.99,"expiration_date":"2029-04-02","underlying":"Common Stock","underlying_shares":10106},"source":{"system":"sec-edgar","filing":"0001209191-19-023845","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000120919119023845/doc4.xml","form_type":"4"}},{"id":3791730,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-10-12T20:38:26.000Z","date":"2018-10-11","kind":"purchase","acquired":true,"shares":10000,"price":4.7697,"value":47697.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $4.67 to $4.96, inclusive. The reporting person undertakes to provide to the issuer, any security holder of issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each price within the ranges set forth in this footnote to this Form 4."}],"balance_after":12827,"source":{"system":"sec-edgar","filing":"0001209191-18-054894","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000120919118054894/doc4.xml","form_type":"4"}},{"id":3880312,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-06-29T23:01:18.000Z","date":"2018-06-28","kind":"sale","acquired":false,"shares":32000,"price":10,"value":320000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."}],"balance_after":125247,"source":{"system":"sec-edgar","filing":"0000899243-18-018764","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924318018764/doc4.xml","form_type":"4"}},{"id":3881172,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-06-28T20:41:09.000Z","date":"2018-06-27","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":6.46,"expiration_date":"2028-06-26","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-18-039883","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000120919118039883/doc4.xml","form_type":"4"}},{"id":4002830,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-03-09T23:00:50.000Z","date":"2018-03-07","kind":"sale","acquired":false,"shares":5000,"price":10,"value":50000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Includes 4,876 shares acquired under the employee stock purchase plan purchased in July 2017 and in January 2018."}],"balance_after":157247,"source":{"system":"sec-edgar","filing":"0000899243-18-006980","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924318006980/doc4.xml","form_type":"4"}},{"id":4036546,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-02-23T22:00:42.000Z","date":"2018-02-22","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on February 22, 2019, and the remainder vests in equal monthly installments thereafter over 36 months"}],"balance_after":275000,"derivative":{"exercise_price":7.77,"expiration_date":"2028-02-22","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000899243-18-005332","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924318005332/doc4.xml","form_type":"4"}},{"id":4105006,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2018-01-05T21:24:29.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":3426,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Grant to the Reporting Person of a stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). The shares vest in four equal\nquarterly installments beginning on January 1, 2018 through December 31, 2018, provided that at the relevant vesting dates the Reporting\nPerson's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The option expires 10 years\nafter the date of grant."}],"balance_after":3426,"derivative":{"exercise_price":9.72,"expiration_date":"2028-01-02","underlying":"Common Stock","underlying_shares":3426},"source":{"system":"sec-edgar","filing":"0001209191-18-002465","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000120919118002465/doc4.xml","form_type":"4"}},{"id":4122193,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-12-22T23:08:25.000Z","date":"2017-12-20","kind":"sale","acquired":false,"shares":12000,"price":8,"value":96000.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 765 shares previously reported as holdings of the Reporting Person granted pursuant to a restricted stock award under the Issuer's 2016 Equity Incentive Plan."}],"balance_after":2827,"source":{"system":"sec-edgar","filing":"0001209191-17-067133","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000120919117067133/doc4.xml","form_type":"4"}},{"id":4187870,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-10-11T22:03:01.000Z","date":"2017-10-09","kind":"grant","acquired":true,"shares":275000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests and becomes exercisable based on the Issuer's common stock price during the two years after the first anniversary of the date of grant as follows: 25% of shares subject to the option vest after the stock price is equal to or greater than $10.00 per share for 20 consecutive trading days; and an additional 6.25% of the shares subject to the option vest for every additional $2.50 in stock price above $10.00 per share for 20 consecutive trading days."}],"balance_after":275000,"derivative":{"exercise_price":3.4,"expiration_date":"2027-10-09","underlying":"Common Stock","underlying_shares":275000},"source":{"system":"sec-edgar","filing":"0000899243-17-024049","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924317024049/doc4.xml","form_type":"4"}},{"id":4268895,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-06-30T21:21:20.000Z","date":"2017-06-28","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Automatic non-discretionary grant to the Reporting Person of a nonstatutory stock option under the Issuer's 2016 Equity Incentive Plan (the \"Plan\") in accordance with the Issuer's Amended and Restated Non-Employee Director Compensation Policy. One hundred percent (100%) of the shares subject to the option shall vest on the earlier of (i) the one-year anniversary of the date of grant or (ii) the date of the next annual meeting of the Issuer's stockholders following the date of grant, subject in each case to the Reporting Person's continued service on such vesting date."}],"balance_after":12000,"derivative":{"exercise_price":12.06,"expiration_date":"2027-06-27","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-17-042571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000120919117042571/doc4.xml","form_type":"4"}},{"id":4320367,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-16T00:22:23.000Z","date":"2017-05-11","kind":"exercise","acquired":false,"shares":68073,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.82,"expiration_date":"2020-03-10","underlying":"Common Stock","underlying_shares":68073},"source":{"system":"sec-edgar","filing":"0000899243-17-013254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924317013254/doc4.xml","form_type":"4"}},{"id":4320366,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-05-16T00:22:23.000Z","date":"2017-05-11","kind":"exercise","acquired":false,"shares":6210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.75,"expiration_date":"2019-03-18","underlying":"Common Stock","underlying_shares":6210},"source":{"system":"sec-edgar","filing":"0000899243-17-013254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924317013254/doc4.xml","form_type":"4"}},{"id":4320365,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy","published_at":"2017-05-16T00:22:23.000Z","date":"2017-05-11","kind":"exercise","acquired":false,"shares":18928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fully vested."}],"balance_after":0,"derivative":{"exercise_price":0.75,"expiration_date":"2018-12-15","underlying":"Common Stock","underlying_shares":18928},"source":{"system":"sec-edgar","filing":"0000899243-17-013254","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924317013254/doc4.xml","form_type":"4"}},{"id":4320364,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-05-16T00:22:23.000Z","date":"2017-05-11","kind":"exercise","acquired":true,"shares":68073,"price":0.82,"value":55819.86,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan on January 1, 2017."}],"balance_after":157371,"source":{"system":"sec-edgar","filing":"0000899243-17-013254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924317013254/doc4.xml","form_type":"4"}},{"id":4320363,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-05-16T00:22:23.000Z","date":"2017-05-11","kind":"exercise","acquired":true,"shares":6210,"price":0.75,"value":4657.5,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan on January 1, 2017."}],"balance_after":89298,"source":{"system":"sec-edgar","filing":"0000899243-17-013254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924317013254/doc4.xml","form_type":"4"}},{"id":4320362,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Common Stock","published_at":"2017-05-16T00:22:23.000Z","date":"2017-05-11","kind":"exercise","acquired":true,"shares":18928,"price":0.75,"value":14196.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 224 shares acquired under Zafgen, Inc.'s 2014 Employee Stock Purchase Plan on January 1, 2017."}],"balance_after":83088,"source":{"system":"sec-edgar","filing":"0000899243-17-013254","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924317013254/doc4.xml","form_type":"4"}},{"id":4370041,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2017-03-28T21:15:30.000Z","date":"2017-03-24","kind":"grant","acquired":true,"shares":1191,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Grant to the Reporting Person of a stock option under the Plan. The shares vest in three equal quarterly installments beginning on April 1, 2017 through December 31, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan. The option expires 10 years after the date of grant."}],"balance_after":1191,"derivative":{"exercise_price":11.8,"expiration_date":"2027-03-23","underlying":"Common Stock","underlying_shares":1191},"source":{"system":"sec-edgar","filing":"0001209191-17-023165","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000120919117023165/doc4.xml","form_type":"4"}},{"id":4370040,"issuer":{"id":4316,"kind":"organization","name":"Viridian Therapeutics, Inc.\\DE"},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2017-03-28T21:15:30.000Z","date":"2017-03-24","kind":"grant","acquired":true,"shares":778,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Grant to the Reporting Person of a restricted stock award under the Issuer's 2016 Equity Incentive Plan (the \"Plan\"). The shares vest in three equal quarterly installments beginning on April 1, 2017 through December 31, 2017, provided that at the relevant vesting dates the Reporting Person's continuous service to the Issuer has not been terminated as defined in and as determined under the Plan."}],"balance_after":14840,"source":{"system":"sec-edgar","filing":"0001209191-17-023165","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1590750/000120919117023165/doc4.xml","form_type":"4"}},{"id":4475023,"issuer":{"id":5634,"kind":"organization","name":"Larimar Therapeutics, Inc."},"owners":[{"id":148980,"kind":"person","name":"Hughes Thomas E.","position":1,"cik":"0001611048","reported_name":"Hughes Thomas E.","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (Right to Buy)","published_at":"2017-01-31T22:32:13.000Z","date":"2017-01-27","kind":"grant","acquired":true,"shares":319000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of this option vests on January 27, 2018, and the remainder vests in equal monthly installments thereafter over 36 months."}],"balance_after":319000,"derivative":{"exercise_price":4.05,"expiration_date":"2027-01-27","underlying":"Common Stock","underlying_shares":319000},"source":{"system":"sec-edgar","filing":"0000899243-17-002289","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1374690/000089924317002289/doc4.xml","form_type":"4"}}]}